KTG-21721-20222
2 vaccinations
2 coded responses
3 check-ins
2 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 05-11
- ZIP prefix
- 970 / OR
- Registered
- 2021-12-04
- Relationship
- Child or adolescent in my care
- Guardian
- ZLA-25397-83354
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-17
Dose 1 — Pfizer-BioNTech
-
2021-12-04
Registered in v-safe
- 2021-12-04
-
2021-12-08
Dose 2 — Pfizer-BioNTech
-
2021-12-17
Survey response — day 7, dose 2, dependentMedDRA: Nasopharyngitis — Feeling: FairFree text: Got a mild cold 4 days after the vaccineMedDRA releases: 2024-11 · check-in free text available
-
2022-03-09
Survey response — 3 months, dose 2, dependentMedDRA: Fatigue, Nasal congestion, Pain, Pyrexia — Feeling: Good · Be unable to work or attend schoolFree text: Fever, body aches, stuffy nose, fatigue started 2/16/22.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-17 | Pfizer-BioNTech | No |
| 2 | 2021-12-08 | Pfizer-BioNTech | No |
Free text
Release 10 — day 7, dose 2, dependent
Systemic reaction (other): Got a mild cold 4 days after the vaccine
Release 11 — 3 months, dose 2, dependent
Symptoms: Fever, body aches, stuffy nose, fatigue started 2/16/22.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SRO | Nasopharyngitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release